|
|
| | trabodenoson Basic information |
| Product Name: | trabodenoson | | Synonyms: | trabodenoson;((2R,3S,4R,5R)-5-(6-(CYCLOPENTYLAMINO)-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL NITRATE;Adenosine, N-cyclopentyl-, 5'-nitrate;INO-8875;INNO-8875;N-Cyclopentyladenosine 5'-nitrate;PJ 875;N-Cyclopentyladenosine 5'-nitrate | | CAS: | 871108-05-3 | | MF: | C15H20N6O6 | | MW: | 380.36 | | EINECS: | | | Product Categories: | | | Mol File: | 871108-05-3.mol |  |
| | trabodenoson Chemical Properties |
| Boiling point | 691.2±65.0 °C(Predicted) | | density | 1.87±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: soluble | | form | A crystalline solid | | pka | 12.99±0.70(Predicted) | | color | White to yellow |
| | trabodenoson Usage And Synthesis |
| Uses | Trabodenoson alters ECM turnover by TM cells and increases conventional outflow facility, which accounts for its ability to lower IOP in young and aged mice. |
| | trabodenoson Preparation Products And Raw materials |
|